Results
20,303 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 |  Michael A. RulliRSelf |  MSFTMICROSOFT CORPPartial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 28, 2026 | |
Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Michael A. RulliRSelf | MSFTMICROSOFT CORP Partial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 28, 2026 | |
Kleinerman ChristianEVP, Product Management |
 SNOWSnowflake Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $5.12M 15.0K sh |
| Oct 2, 2026 traded Oct 1, 2026 |
| 30 | Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks |  IRDOpus Genetics, Inc.Open-market sale | SELL | $2.76M 556.0K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 27 | Colendich Katie MarieGC, Corporate Secretary |  ASANAsana, Inc.Open-market sale | SELL | $55K 6,318 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 21 | Spice Adam C.Chief Financial Officer |  RKLBRocket Lab CorpOpen-market sale · 10b5-1 plan | SELL | $6.05M 85.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 21 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $435K 16.1K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 21 | Lee Chan HenrySVP, General Counsel |  ONCBeOne Medicines Ltd.Open-market sale · 10b5-1 plan | SELL | $418K 1,115 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 20 | Michael A. RulliRSelf |  WFCWELLS FARGO & COMPANY/MNPartial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 3, 2026 |
| 18 | Serafini John SheldonDirector, President and CEO |  HAWKHawkEye 360, Inc.Open-market sale · 10b5-1 plan | SELL | $1.36M 92.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | RKLBRocket Lab Corp Open-market sale · 10b5-1 plan | SELL | $2.79M 39.7K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | RKLBRocket Lab Corp Open-market sale · 10b5-1 plan | SELL | $1.09M 15.2K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 16 | Gimbel LisaCHIEF ACCOUNTING OFFICER |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $9,495 500 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 11 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $1.66M 17.0K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $1.64M 17.0K sh | Oct 2, 2026 traded Oct 2, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $766K 1,846 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $394K 954 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO |  NEMNEWMONT Corp /DE/Open-market sale · 10b5-1 plan | SELL | $446K 3,882 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Raghavan VaidyanathanChief Technology Officer |  XMTRXometry, Inc.Open-market sale · 10b5-1 plan | SELL | $56K 549 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 200 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $66K 2,025 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 6 | Abdelsadek MohamedEVP, Chief Global Solutions |  TRUTransUnionOpen-market sale · 10b5-1 plan | SELL | $16K 250 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 4 | Johnston James DavidExecutive VP, GC, CCO and Secy |  SMCSummit Midstream CorpOpen-market sale · 10b5-1 plan | SELL | $79K 2,600 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $7,726 74 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $3,401 32 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 247 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 373 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $35K 343 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $34K 317 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 267 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 228 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 264 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $30K 284 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 2 | Kerdman AlinaSVP, Controller & CAO |  CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPOpen-market sale · 10b5-1 plan | SELL | $7,906 139 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 0 | Allan JonathanGENERAL COUNSEL & CORP SEC |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $17K 627 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 0 | McNamara PeterChief Scientific Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $12K 536 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 42 | Smith Nicholas ConradPRESIDENT AND CFO |  ANROAlto Neuroscience, Inc.Open-market sale | SELL | $2.95M 110.8K sh | Oct 1, 2026 traded Sep 29, 2026 |
| 40 | Sanders Corazon (Corsee) D.Director |  LEGNLegend Biotech CorpOpen-market sale | SELL | $259K 27.4K sh | Oct 1, 2026 traded Sep 29, 2026 |
| 39 | Schuetz Arthur Josef HermannCFO Schmid Group N.V. |  SHMDSCHMID Group N.V.Open-market sale | SELL | $51K 11.4K sh | Oct 1, 2026 traded Sep 30, 2026 |
| 38 | Long QuanDirector |  ATHMAutohome Inc.Open-market sale | SELL | $182K 34.4K sh | Oct 1, 2026 traded Sep 30, 2026 |
| 31 | Heller Gregory JohnEVP, CLO & Secretary |  BATRKAtlanta Braves Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $4.33M 80.3K sh | Oct 1, 2026 traded Sep 29, 2026 |